Preclinical prevent cancer program: preclinical efficacy and intermediate endpoint biomarkers

Ended Awarded Last action

Contract number
HHSN261201500039I
Awardee
Awarding agency
Task orders
5 $3,649,729 obligated

Award facts

Combined order value
$3,649,729 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 12% used
$29,800,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 9 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Frameshift peptide vaccine for the prevention lynch syndrome-associated gastrointestinal cancer HHSN2612015000391… 75N91018F00005 National Cancer Institute (NIH) $891,984
Anti fusobacterium nucleatum vaccine for colorectal cancer immunoprevention HHSN26100004 National Cancer Institute (NIH) $1,246,582
R & d- medical: biomedical (basic research) HHSN26100002 National Cancer Institute (NIH) $679,923
Testing of combination immuno and chemoprevention strategies for lynch syndrome gastrointestinal cancer HHSN26100003 National Cancer Institute (NIH) $828,445
Contract orientation and kickoff meeting HHSN26100001 National Cancer Institute (NIH) $2,795

Transactions

Action Obligated Date
Other Administrative Action P00003 $0
Other Administrative Action 2 · Efficacy idiqs- increase programmatic maximum $0
Other Administrative Action 1 $0
Original award $0

Subawards

Subcontractor Amount Awarded
Deutsches Krebsforschungszentrum IGF::OT::IGF CHEMOPREVENTION OF ESOPHAGEAL CANCER BY TARGETING MULTIPLE PATHWAYS IN A MOUSE MODEL OF BARRETT'S ESOPHAGUS A major research focus of the… $478,148
The Trustees Of Columbia University In The City Of New York IGF::OT::IGF CHEMOPREVENTION OF ESOPHAGEAL CANCER BY TARGETING MULTIPLE PATHWAYS IN A MOUSE MODEL OF BARRETT'S ESOPHAGUS The overall objective of this task… $634,500

Quick answers

Who was awarded contract HHSN261201500039I?

HHSN261201500039I was awarded to Weill Medical College Of Cornell University by National Cancer Institute (National Institutes of Health) on September 22, 2015.

How much is contract HHSN261201500039I worth?

Orders under HHSN261201500039I have obligated $3,649,729. HHSN261201500039I's own ceiling is $29,800,000.

How many orders have been placed under contract HHSN261201500039I?

5 orders have been placed under HHSN261201500039I, the latest on September 13, 2018.

Who can order from contract HHSN261201500039I?

HHSN261201500039I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN261201500039I part of a contract vehicle?

Yes. HHSN261201500039I is part of PREVENT Cancer Program (PREVENT).

Was contract HHSN261201500039I competed?

The extent of competition for HHSN261201500039I was full and open competition. The government received 9 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login